Figdor Drew 13D/13G Filings for TransCode Therapeutics, Inc. (RNAZ)

Figdor Drew 13D and 13G filings for TransCode Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-01-13
5:28 pm
Purchase
2023-01-03 13D TransCode Therapeutics, Inc.
RNAZ
Figdor Drew 366
8.500%
366increase
(New Position)
Filing